跳至主要内容
临床试验/ISRCTN98465849
ISRCTN98465849进行中(未招募)未知

Assessing weight loss, adverse events, and resolution of comorbid conditions associated with the use of the BariClip device in adult patients with severe obesity in Jordan

Jordan Hospital0 个研究点目标入组 50 人开始时间: 2023年2月16日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18 – 65 years
  • 2. Male or female
  • 3. BMI >40 kg/m² and BMI >30 kg/m² with at least one comorbid condition (hypertension [HTN], type 2 diabetes [DT2], sleep apnea)
  • 4. Willingness to comply with the substantial lifelong dietary restrictions required by the procedure (written consent form)
  • 5. History of obesity for at least 5 years
  • 6. History of failure with dieting methods
  • 7. Willingness to follow protocol requirements including signed consent, routine follow-up schedule, completing quality of life (QOL) questionnaires, completing laboratory tests, completing diet and behavior modification counseling
  • 8. Residing within a reasonable distance from an investigating center and able to travel to the investigator to complete all routine follow-up visits

排除标准

  • 1. Surgery or treatment represents an unreasonable risk to the subject
  • 2. Patient history of inflammatory disease of the gastrointestinal (GI) tract (including ulceration, duodenal ulceration, grade 4 esophagitis, specific inflammation such as Crohn’s disease or ulcerative colitis)
  • 3. Severe cardiopulmonary disease or other serious organic disease
  • 4. Severe coagulopathy, upper gastrointestinal (UGI) bleeding conditions, such as esophageal or gastric varices, congenital or acquired intestinal telangiectasia
  • 5. Congenital or acquired anomalies of the GI
  • 6. Severe hiatal hernia (>3 cm)
  • 7. Pregnant or has the intention of becoming pregnant in the next 12 months
  • 8. Alcohol or drug addiction, active smoker
  • 9. Mental retardation or emotional instability, or psychological characteristics which, in the opinion of the investigators, make the subject a poor candidate for clip surgery
  • 10. Previous esophageal, gastric surgery, hepatectomy, splenectomy
  • 11. Previous endoscopic procedure for obesity
  • 12. Patient under GLP1 medication or weight loss drug
  • 13. Diabetes patient under treatment for gastroparesis
  • 14. Previous bariatric surgery, intestinal obstruction, or adhesive peritonitis
  • 15. Patient history of a known diagnosis or pre-existing symptoms of systemic lupus erythematosus, scleroderma, or other autoimmune connective tissue disorder
  • 16. Participating in another ongoing clinical trial in which concomitant diagnosis or therapeutic intervention would adversely affect the integrity of the Clip clinical trial

研究者

相似试验